GMMMG holds open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by GMMMG for information or approval, as appropriate.

Consultations typically run for six weeks, and comments are invited from all stakeholders across Greater Manchester. You can comment on current proposals via the links in the table below.

Please direct any questions to the secretariat at nuth.enquiries.gmmmg@nhs.net.

Title Information Feedback End Date
GMMMG Clinical Reference Group proposed actions from July 2022 On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the July 2022 CRG meeting. This consultation period is open until 5pm on Monday 5th September 2022. Feedback Form September 5th, 2022
Adoption of national shared care protocols in Greater Manchester On behalf of the GMMMG Clinical Reference Group, we now seek comments on the adoption and implementation in Greater Manchester of the national shared care protocols published by NHSE. This consultation will run for 8 weeks, and is open until 5pm on Monday 19th September 2022 Feedback Form September 19th, 2022
GMMMG shared care protocol – sodium zirconium cyclosilicate (Lokelma) On behalf of the GMMMG Clinical Reference Group, we now seek comments on a draft shared care protocol for sodium zirconium cyclosilicate (Lokelma). This consultation period is open until 5pm on Monday 12th September 2022 Feedback Form September 12th, 2022
GMMMG shared care protocol – patiromer (Veltassa) On behalf of the GMMMG Clinical Reference Group, we now seek comments on a draft shared care protocol for patiromer (Veltassa). This consultation period is open until 5pm on Monday 12th September 2022 Feedback Form September 12th, 2022
GMMMG DOAC Statement
[link removed - consultation closed]
On behalf of the GMMMG Clinical Reference Group, we now seek comments on a statement on choice of DOAC for treatment of non-valvular atrial fibrillation. This consultation period is open until 5pm on Monday 1st August 2022 [link removed - consultation closed] August 1st, 2022
GMMMG Hypersalivation Pathway
[link removed - consultation closed]
On behalf of the GMMMG Clinical Reference Group, we now seek comments on a draft pathway for management of hypersalivation. This consultation period is open until 5pm on Monday 1st August 2022 [link removed - consultation closed] August 1st, 2022